Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinosarcoma, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Carcinoma, Merkel Cell, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT05758688 2026-03-12

PROPS GYN

Phase 2 Recruiting

25 enrolled

Gynecologic

Uterine Cervical Neoplasms, Uterine Neoplasms, Endometrial Neoplasms

NCT05763199 2026-03-12

Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy

Phase 2 Active not recruiting

20 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT06349642 2026-03-12

ELEPHAS-04

Recruiting

324 enrolled

DermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Clear-cell metastatic renal cell carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinosarcoma, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Neoplasm Metastasis, Skin Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT07050771 2026-03-12

Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery

Phase 2 Recruiting

148 enrolled

GenitourinaryGynecologic

Urinary Bladder Neoplasms, Kidney Neoplasms, Neoplasms, Ovarian Neoplasms

NCT07461207 2026-03-12

TEX-MECS

Not yet recruiting

120 enrolled

Gynecologic

High-grade Serous Ovarian Carcinoma (HGSOC)

NCT07466901 2026-03-12

A Single-arm, Multicenter, Phase II Clinical Study of Camrelizumab Combined With Famitinib in Adjuvant Therapy After Radical Resection of Cervical Cancer

Phase NA Not yet recruiting

30 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT07467772 2026-03-12

Ph 2 Elacestrant in ER Positive Uterine Sarcomas

Phase 2 Not yet recruiting

30 enrolled

GynecologicSarcoma

Adenosarcoma of the uterus, Sarcoma, Endometrial Stromal, Perivascular Epithelioid Cell Neoplasms

NCT07468578 2026-03-12

Community Implementation of Urine HPV Test and Reflex DNA Methylation Test in Cervical Cancer Screening

Not yet recruiting

8,620 enrolled

Gynecologic

Cervical Cancer Screening

NCT07468695 2026-03-12

Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS2 Kenya

Phase NA Not yet recruiting

300 enrolled

Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia

NCT03586661 2026-03-11

Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Phase 1 Active not recruiting

31 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Disease Progression

NCT03968406 2026-03-11

Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers

Phase 1 Recruiting

24 enrolled

Gynecologic

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Endometrial Neoplasms

NCT04344899 2026-03-11

PORTS

Completed

74 enrolled

Gynecologic

Pelvic Neoplasms

NCT05819892 2026-03-11

Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer

Phase 1 Recruiting

21 enrolled

Gynecologic

Endometrial Neoplasms

NCT05952453 2026-03-11

Newly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Maintenance Olaparib/Pembro

Phase 2 Recruiting

20 enrolled

Gynecologic

Ovarian Neoplasms

NCT07461818 2026-03-11

POC

Phase NA Recruiting

5,000 enrolled

Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

NCT07465133 2026-03-11

EORTC QOL-OV39

Not yet recruiting

50 enrolled

Gynecologic

Ovarian Neoplasms

NCT02867956 2026-03-10

Apatinib and Etoposide in Patients With Platinum Resistant or Refractory Ovarian Cancer

Phase 2 Completed

35 enrolled

Gynecologic

Ovarian Neoplasms

NCT03367247 2026-03-10

BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and Renewal

Phase NA Completed

121 enrolled 16 charts

GastrointestinalGynecologic

Ascites, Gastrointestinal Neoplasms, Ovarian Neoplasms

Clinical Trials

CoHIPP

TILsOV

ACCRAPAN

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

Analysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO Study

Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT

CervImage

A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer

TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk Patients

FIMBRIMENOP

BCB-OVAIRE

KETOCOL

Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule

CHIPPI

Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer

A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients

The PIPAC-OPC7 Study: The Use of PET/CT Scans as a Method of Evaluation in Patients Treated With PIPAC, a Pilot Study.

CATSystem

Study Evaluating Safety, Tolerability, and Metabolism of Niraparib

MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer

YS247

ROBO-GYN

ANOXICOL

TEP-Curie

Self-Hypnosis for the Enhanced Recovery After Surgery in Patients With Gynecologic Cancer

Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer

Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians

FEMUS

PRO-ACTIVE

Mobile App-Supported HPV and Breast Cancer Awareness Program

Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor

PNeoVCA

PROPS GYN

Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy

ELEPHAS-04

Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery

TEX-MECS

A Single-arm, Multicenter, Phase II Clinical Study of Camrelizumab Combined With Famitinib in Adjuvant Therapy After Radical Resection of Cervical Cancer

Ph 2 Elacestrant in ER Positive Uterine Sarcomas

Community Implementation of Urine HPV Test and Reflex DNA Methylation Test in Cervical Cancer Screening

Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS2 Kenya

Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers

PORTS

Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer

Newly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Maintenance Olaparib/Pembro

POC

EORTC QOL-OV39

Apatinib and Etoposide in Patients With Platinum Resistant or Refractory Ovarian Cancer

BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and Renewal